Bionor Pharma is a leading vaccine company, searching for breakthrough treatments for HIV and other deadly viruses.

Modified Peptide based vaccinesen/Vaccines_+_technology/Platform_technology/The key to kill virusen/Vaccines_+_technology/Platform_technology/Vacc-4x kills virus producing cells.en/Vaccines_+_technology/HIV_vaccine_Vacc-4x/

Latest news

Hide mandatory notifications of trade

Bionor Pharma - Second quarter results 2014

Financial .2014

(Oslo, 15.08.2014) Bionor Pharma ASA (OSE: BIONOR) announced today its financial results for the second quarter and first half of 2014 and update on its clinical development program.

Invitation to Webcast of Bionor Pharma Q2 2014 Results 15 August

Financial .2014

(Oslo, 14.08.2014) Bionor Pharma ASA (OSE:BIONOR) will announce its second quarter 2014 results 15 August 2014 at 7.00 CEST.

Bionor Pharma - Second quarter results 2014

Financial .2014

(Oslo, 15.08.2014) Bionor Pharma ASA (OSE: BIONOR) announced today its financial results for the second quarter and first half of 2014 and update on its clinical development program.

Invitation to Webcast of Bionor Pharma Q2 2014 Results 15 August

Financial .2014

(Oslo, 14.08.2014) Bionor Pharma ASA (OSE:BIONOR) will announce its second quarter 2014 results 15 August 2014 at 7.00 CEST.

Go to news section

Featured content